← Human Trials & Peer-Reviewed Studies
Effects of dietary intervention on vitamin B12 status and cognitive level of 18-month-old toddlers in high-poverty areas: a cluster-randomized controlled trial.
Plain-language guide to PMID 31519167 (2019): randomized controlled trial of Cyanocobalamin (Vitamin B12).
Key Facts
- PMID
- 31519167
- Journal
- BMC pediatrics
- Year
- 2019
- Study type
- Randomized Controlled Trial
- Authors
- Sheng X et al. (5 authors)
- DOI
- 10.1186/s12887-019-1716-z
- Registered trial
- NCT00726102
What This Study Did, in Plain Language
What Was Tested
Researchers studied Cyanocobalamin (Vitamin B12) in this randomized controlled trial publication.
The aims of this study were to explore the vitamin B12 status of toddlers living in high-poverty areas of China and to observe the effects of different complementary foods on the vitamin B12 status and cognitive level of these toddlers.
Why It Was Studied
The local diet in high-poverty areas in China is mainly vegetarian, and children may be more vulnerable to vitamin B12 deficiency.
The larger trial in which this study was nested was registered at clinical trials.gov as NCT00726102.
Who Took Part
By PubMed's age tags, the people studied were infants, both men and women.
At 18 months, a subsample of the 180 toddlers (60 from each group) was randomly tested for serum vitamin B12 and total homocysteine (tHcy) levels, and their neurodevelopment was evaluated.
How the Study Was Run
The researchers set it up as a randomized study.
The participants were allocated by chance, so the Cyanocobalamin (Vitamin B12) group and the comparison group should start out alike.
What Was Measured
The subject headings attached to it are Anemia, Child Development, China, Cognition, Diet, Edible Grain and Food, Fortified.
Author keywords: Complementary food, Deficiency, Neurodevelopment, Toddler and Vitamin B12.
What This Means in Plain Language
The paper is a randomized study of Cyanocobalamin (Vitamin B12).
Its findings take up roughly 8 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.
The publication is from 2019 (BMC pediatrics), a journal based in England.
More context: the Cyanocobalamin (Vitamin B12) compound page, all human trials.
Our Notes on the Compound
Cyanocobalamin (Vitamin B12): A synthetic form of vitamin B12 (cobalamin), an essential nutrient for DNA synthesis, red blood cell formation and neurological function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.